Security record · archived quarter
TECH
Bio-Techne Corporation · Healthcare · Biotechnology
12Tracked holders
0Δ holders
29.06MShares held
$2.09BReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +0.2% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 147 | +11 | 118.94M | $8.37B | +19 | −7 |
| Q1 2026 | 138 | +4 | 119.63M | $6.27B | +11 | −8 |
| Q4 2025 | 133 | -3 | 119.40M | $7.02B | +1 | −3 |
| Q3 2025 | 21 | +2 | 61.92M | $3.44B | +4 | −3 |
| Q2 2025 | 17 | 0 | 59.03M | $3.04B | +2 | −2 |
| Q1 2025 | 14 | +2 | 27.35M | $1.60B | +3 | −1 |
| Q4 2024 | 12 | 0 | 29.06M | $2.09B | +1 | −1 |
| Q3 2024 | 11 | +1 | 22.54M | $1.80B | +2 | −1 |
| Q2 2024 | 10 | — | 19.47M | $1.39B | — | — |
Who holds it · Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.65M | +13.1% | $767.43M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.65M | +13.1% | $767.43M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 6.47M | — | $466.25M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 4.00M | +2.5% | $287.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 4.00M | +2.5% | $287.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 1.91M | +0.1% | $137.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.76M | +46.0% | $126.63M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.76M | +46.0% | $126.63M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 1.52M | -13.6% | $109.68M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.44M | -6.1% | $103.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.44M | -6.1% | $103.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 1.44M | -6.1% | $103.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 1.44M | -6.1% | $103.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 655.79K | -48.4% | $47.24M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 498.50K | +54.1% | $35.91M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 58.15K | +0.1% | $4.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 58.15K | +0.1% | $4.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 58.15K | +0.1% | $4.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 54.70K | New | $3.94M | 0.0% | New | 1 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 38.50K | +8.2% | $2.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $3.94M | 0.0% |
Exited
| Point72 Asset Management | $89.72M | was 0.3% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 426.80K shares, $22,304 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Aug 06
SC 13G/A — FMR LLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q4 2024 ·
Methodology ·
Get this via the API